In our study, downregulating the expression of BTLA by a monoclonal antibody on tumor-infiltrating NKT cells induced protective immunity, likely due to the expansion of NK1.1+ T cells, as well as, or including, type I NKT cells. This evidence concerns the gene BTLA and neoplasm.